NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...

If you suffered substantial losses and wish to serve as lead plaintiff of the AstraZeneca class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or ...

SAN DIEGO, Jan. 16, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC ...

NEW YORK , Jan. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class ...

THE LAWSUIT: A class action securities lawsuit was filed against AstraZeneca PLC that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February ...

triggering a securities class action lawsuit in the United States. Hagens Berman has opened an investigation into the allegations and urges investors in AstraZeneca American Depositary Shares who ...

Captioned Saleh v. AstraZeneca PLC, No. 24-cv-11021 (C.D. Cal.), the AstraZeneca class action lawsuit charges AstraZeneca as well as certain of AstraZeneca's top executives with violations of the ...

On news of the details, AstraZeneca ADSs declined, harming investors. What Now : You may be eligible to participate in the class action against AstraZeneca PLC. Shareholders who want to serve as ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dat ...

Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In AstraZenecaTo Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in AstraZeneca between ...

Captioned Saleh v. AstraZeneca PLC, No. 24-cv-11021 (C.D. Cal.), the AstraZeneca class action lawsuit charges AstraZeneca and certain of AstraZeneca’s top executives with violations of the ...